Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC
Clinical trial NCT04157140 · UNKNOWN
Trial details
- NCT number
- NCT04157140
- Sponsor
- Jinglong Chen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-28
- Primary completion
- 2022-09-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.